Objectives To provide a succinct, clinically useful summary of the management of bipolar
disorder, based on the 2020 Royal Australian and New Zealand College of Psychiatrists�…

Bipolar disorder (BD) is a mood disorder with subtypes characterized by episodes of mania,
hypomania, and/or depression. BD is associated with substantial economic burden, and the�…

Bipolar disorder is heterogeneous in phenomenology, illness trajectory, and response to
treatment. Despite evidence for the efficacy of multimodality interventions, the majority of�…

Background Antidepressants are used to treat acute depression in patients with bipolar I
disorder, but their effect as maintenance treatment after the remission of depression has not�…

Background Severe mental illness (SMI; schizophrenia, bipolar disorders (BDs), and other
nonorganic psychoses) is associated with increased risk of cardiovascular disease (CVD)�…

The efficacy of ketamine in reducing suicidal ideation (SI) has been previously reported. We
aimed to evaluate acute anti-SI effects of single-dose ketamine in different�…

Importance Although suicide attempts remain the strongest risk factor for future suicide, little
is known about recent trends in the prevalence of and risk factors for suicide attempts and�…

Objectives To understand treatment practices for bipolar disorders (BD), this study leveraged
the Global Bipolar Cohort collaborative network to investigate pharmacotherapeutic�…

Background Suicide is a public health crisis. We conducted a systematic review and meta‐
analysis of the effects of psychopharmacologic and somatic therapies on suicide risk�…

Background Schizophrenia and antipsychotic use are associated with clinically significant
weight gain and subsequent increased mortality. Despite weight loss medications (WLMs)�…